Next-generation imaging technology for nuclear medicine.
Terapet SA
Incorporated
19.12.2019Headquarters
SatignySupport
Terapet SA,, a CERN spin-off in MedTech, was incorporated in Geneva, Switzerland on 19.12.2019. The founders are two CERN physicists, Dr. Christina Vallgren (PhD in Applied Physics, MSc in Nuclear Physics and MBA), Dr. Marcus Palm (PhD in Applied Physics, MSc in Engineering Physics and Electronics) and a leading radiation oncologist, Prof. Raymond Miralbell (Radiation Oncologist 40+ years). Terapets core technology is an innovative platform technology for imaging in nuclear medicine and radiotherapy. On June 13, 2025, Terapet SA successfully achieved ISO 13485:2016 certificationa major milestone that underscores the companys commitment to innovation, quality, regulatory compliance, and, ultimately, improved patient care.
News
Innosuisse funded 45 Start-up innovation projects (startupticker.ch)
European funds to propel Swiss projects (startupticker.ch)
Twenty-eight startups selected for the Innosuisse Scale up Coaching (startupticker.ch)
Collaborative success: Terapet's partnership with Yonsei University and Oncosoft Inc. secures multi-million funding from Innosuisse and KIAT (venturelab.swiss)
International grants fuel medical and sustainable solutions (startupticker.ch)
First National Flagship Event 2023: Credit Suisse Investors and TOP 100 Startups connect over archery in Lausanne (venturelab.swiss)
Lifesciences startups mature for sustainable growth (startupticker.ch)
New FONGIT Innovation Initiation Program launched (startupticker.ch)
CHF 2.3M to market Terapet first product and boost R&D (startupticker.ch)
The 16 most promising medtech startups in 2022, according to investors (TOP 100)
FIF funding supports three women led deeptech startups (startupticker.ch)
Good Morning Startups 2022: Credit Suisse investors and TOP 100 startups connect over breakfast (venturelab.swiss)
Thirteen startups explore East and West Coast expansion opportunities (startupticker.ch)
Venture Leaders Life Sciences and Medtech pitch to an audience of international investors, VCs and experts in Harvard, Cambridge (venturelab.swiss)
Joint roadshow in Boston for Venture Leaders Life Sciences 2020 and Medtech 2021 (venturelab.swiss)
Finalists of the W. A de Vigier revealed (startupticker.ch)
17 deep-dech start-ups shortlisted for the W.A. de Vigier Award (startupticker.ch)
CHF1.5 million for making proton therapy safer and faster (startupticker.ch)
Terapet receives €500K Eurostars award allocated to clinical validation (venturelab.swiss)
Terapet remporte CHF 150 000 de Venture Kick (startupticker.ch)
Videos and Presentations
TERAPET: Improving Proton Therapy for Cancer Treatments
Elevator Pitch by our CTO, Marcus Palm. TERAPET was among Top10 at Swiss Innovation Challenge 2019